James T.

Business Reporter

Preston's Summary

James T. is a Business Reporter at Newsday. He focuses on the NY-area economy and government/business issues, while also exploring themes in science and natural sciences, particularly in biology and life sciences, data integrations, and data processing technologies. James has been featured in notable publications including Nature Portfolio, The St. Louis American, and The Washington Times, among others.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

None, United States (Local)

Coverage Attributes:

Beta
Informative: 48 %
Data Driven: 41 %
Opinion: 6 %
Promotional: 3 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Biology & Life Sciences
  • Neuroscience
  • Ecology

Pitching Insights

James T.'s coverage reveals a focus on government announcements, press releases, and data citations. His themes mainly center around business and human resources & employment, covering topics such as medical research, climate change, labor unions, education, and recruitment.

To effectively reach out to James T., consider providing insights into the implications of government announcements or new data within the realms of business or human resources. For example:

- Insights into how governmental decisions impact businesses or employment trends.
- Expert commentary on groundbreaking medical research with potential implications for industry or workforce health.
- Analysis of climate change policies' effects on labor markets and occupational health concerns.

When pitching to James T., it's important to provide fact-based analyses that resonate with his coverage attributes while addressing relevant themes covered in his articles.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Most recent topics
Not enough data
Sophia Ktori
Freelance Writer and Editor Specialising in Life Sciences, Pharmaceuticals and Biotechnology
Most recent topics
Not enough data